Relmada Therapeutics Inc (RLMD) — Cash Flow Quality Index

Latest as of December 2025: -0.39x

Relmada Therapeutics Inc (RLMD) has a Cash Flow Quality Index of -0.39x as of December 2025. Operating cash flow of $-14.60 Million is below net income of $37.52 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Relmada Therapeutics Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-0.39x

Operating CF / Net Income

Operating Cash Flow

$-14.60 Million

USD

Net Income

$37.52 Million

USD

Data as of

Dec 2025

Most recent filing

Annual Cash Flow Quality Index for Relmada Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Relmada Therapeutics Inc. For live market cap and the full company financial profile, see market cap of Relmada Therapeutics Inc.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.